Diagnosis Code C83.72
Information for Medical Professionals
The diagnosis code C83.72 is grouped in the following Diagnostic Related Group(s) (MS-DRG V35.0)
- 820 - LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITH MCC
- 821 - LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITH CC
- 822 - LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITHOUT CC/MCC
Convert to ICD-9
- 200.22 - Burkitt's tumor thorax
- Burkitt's lymphoma of intrathoracic lymph nodes
- Burkitt's tumor of intrathoracic lymph nodes
- Neoplasm of mediastinal lymph nodes
Information for Patients
Also called: Non-Hodgkin lymphoma
Lymphoma is a cancer of a part of the immune system called the lymph system. There are many types of lymphoma. One type is Hodgkin disease. The rest are called non-Hodgkin lymphomas.
Non-Hodgkin lymphomas begin when a type of white blood cell, called a T cell or B cell, becomes abnormal. The cell divides again and again, making more and more abnormal cells. These abnormal cells can spread to almost any other part of the body. Most of the time, doctors don't know why a person gets non-Hodgkin lymphoma. You are at increased risk if you have a weakened immune system or have certain types of infections.
Non-Hodgkin lymphoma can cause many symptoms, such as
- Swollen, painless lymph nodes in the neck, armpits or groin
- Unexplained weight loss
- Soaking night sweats
- Coughing, trouble breathing or chest pain
- Weakness and tiredness that don't go away
- Pain, swelling or a feeling of fullness in the abdomen
Your doctor will diagnose lymphoma with a physical exam, blood tests, a chest x-ray, and a biopsy. Treatments include chemotherapy, radiation therapy, targeted therapy, biological therapy, or therapy to remove proteins from the blood. Targeted therapy uses substances that attack cancer cells without harming normal cells. Biologic therapy boosts your body's own ability to fight cancer. If you don't have symptoms, you may not need treatment right away. This is called watchful waiting.
NIH: National Cancer Institute
- After chemotherapy - discharge (Medical Encyclopedia)
- B-cell leukemia/lymphoma panel (Medical Encyclopedia)
- Bone marrow transplant (Medical Encyclopedia)
- Burkitt lymphoma (Medical Encyclopedia)
- Lymph node biopsy (Medical Encyclopedia)
- Non-Hodgkin lymphoma (Medical Encyclopedia)
- Non-Hodgkin lymphoma - children (Medical Encyclopedia)
- Understanding Chemotherapy - NIH - Easy-to-Read (National Cancer Institute)
- What to Know about Brachytherapy (A Type of Internal Radiation Therapy) - NIH - Easy-to-Read (National Cancer Institute)
- What to Know about External Beam Radiation Therapy - NIH - Easy-to-Read (National Cancer Institute)
General Equivalence Map Definitions
The ICD-10 and ICD-9 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.
- Approximate Flag - The approximate flag is on, indicating that the relationship between the code in the source system and the code in the target system is an approximate equivalent.
- No Map Flag - The no map flag indicates that a code in the source system is not linked to any code in the target system.
- Combination Flag - The combination flag indicates that more than one code in the target system is required to satisfy the full equivalent meaning of a code in the source system.
Present on Admission
The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement.